QR kód

Delayed Neurologic Response to Dabrafenib and Trametinib in the Case of Mixed Histiocytosis (LCH/ECD): Case Report and Literature Review

<b>Background and Clinical Significance</b>: Histiocytosis encompasses Langerhans cell histiocytosis (LCH) and non-LCH, such as Erdheim–Chester disease (ECD). ECD or a mixed type of histiocytosis (LCH/ECD) may initially involve the central nervous system (CNS), resulting in a delayed diagnosis. More...

Celý popis

Uloženo v:
Hlavní autoři: Shinsaku Imashuku, Miyako Kobayashi, Takashi Miyoshi, Naoyuki Anzai
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI AG 2026-01-01
Edice:Reports
Témata:
Langerhans cell histiocytosis
Erdheim–Chester disease
mixed histiocytosis
dabrafenib
trametinib
neurological symptoms
On-line přístup:https://www.mdpi.com/2571-841X/9/1/18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky